Association of dietary insulinemic and inflammatory potential with risk of liver cancer and chronic liver disease mortality in postmenopausal women: a prospective cohort study.
EDIH
EDIP
chronic liver diseases
empirical dietary index for hyperinsulinemia
empirical dietary inflammation pattern
liver cancer
mortality
prospective cohort study
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
04
04
2023
revised:
07
07
2023
accepted:
13
07
2023
pmc-release:
17
07
2024
medline:
5
9
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
Low diet quality, diabetes, and chronic inflammation are risk factors of liver cancer and chronic liver disease (CLD), but the extent to which insulinemic and inflammatory diets are independently associated with risk of liver cancer and CLD mortality is unknown. We conducted a prospective cohort analysis among 78,356 postmenopausal women in the Women's Health Initiative Observational Study. Two validated dietary indices, the empirical dietary index for hyperinsulinemia (EDIH) and the empirical dietary inflammation pattern (EDIP), were estimated from a food-frequency questionnaire. Incident cases of liver cancer and CLD mortality were adjudicated via review of medical records and linkage to National Death Index. Multivariable hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional hazards models, adjusted for age, diabetes, body mass index, and other covariates. During a median 22.1 y of follow-up, we documented 176 primary liver cancer cases and 156 CLD mortality cases. EDIH was positively associated with incident liver cancer (HR Dietary insulinemic and inflammatory potentials were independently associated with higher risk of liver cancer and CLD mortality in U.S. postmenopausal women. These findings suggest a potential role for diet modification to reduce risk of liver cancer and CLD.
Sections du résumé
BACKGROUND
Low diet quality, diabetes, and chronic inflammation are risk factors of liver cancer and chronic liver disease (CLD), but the extent to which insulinemic and inflammatory diets are independently associated with risk of liver cancer and CLD mortality is unknown.
METHODS
We conducted a prospective cohort analysis among 78,356 postmenopausal women in the Women's Health Initiative Observational Study. Two validated dietary indices, the empirical dietary index for hyperinsulinemia (EDIH) and the empirical dietary inflammation pattern (EDIP), were estimated from a food-frequency questionnaire. Incident cases of liver cancer and CLD mortality were adjudicated via review of medical records and linkage to National Death Index. Multivariable hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional hazards models, adjusted for age, diabetes, body mass index, and other covariates.
RESULTS
During a median 22.1 y of follow-up, we documented 176 primary liver cancer cases and 156 CLD mortality cases. EDIH was positively associated with incident liver cancer (HR
CONCLUSIONS
Dietary insulinemic and inflammatory potentials were independently associated with higher risk of liver cancer and CLD mortality in U.S. postmenopausal women. These findings suggest a potential role for diet modification to reduce risk of liver cancer and CLD.
Identifiants
pubmed: 37460062
pii: S0002-9165(23)66030-7
doi: 10.1016/j.ajcnut.2023.07.009
pmc: PMC10517210
pii:
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
530-537Subventions
Organisme : NHLBI NIH HHS
ID : HHSN268201600001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600003C
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA272452
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA252962
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600004C
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA238651
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600002C
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA259208
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA262299
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Informations de copyright
Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.
Références
Pancreas. 2004 Oct;29(3):231-8
pubmed: 15367890
J Nutr. 2016 Aug;146(8):1560-70
pubmed: 27358416
Int J Cancer. 2020 Aug 15;147(4):1050-1058
pubmed: 32142166
Ann Epidemiol. 2003 Oct;13(9 Suppl):S18-77
pubmed: 14575939
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266
pubmed: 31981519
Oxid Med Cell Longev. 2016;2016:4234061
pubmed: 28070230
Cancer Sci. 2010 May;101(5):1073-9
pubmed: 20345478
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
J Hepatol. 2019 Apr;70(4):674-683
pubmed: 30543829
J Womens Health (Larchmt). 2017 Dec;26(12):1270-1277
pubmed: 28933583
Cancer Res. 2016 Oct 15;76(20):6076-6083
pubmed: 27742674
J Natl Cancer Inst. 2020 Feb 1;112(2):170-178
pubmed: 31184362
Metabolites. 2019 Jun 24;9(6):
pubmed: 31238601
Ann Epidemiol. 2003 Oct;13(9 Suppl):S122-8
pubmed: 14575944
Ann Epidemiol. 1999 Apr;9(3):178-87
pubmed: 10192650
Int J Cancer. 2021 May 1;148(9):2102-2114
pubmed: 33129230
Front Nutr. 2021 Sep 20;8:690428
pubmed: 34616762
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1229-1240
pubmed: 33827986
Control Clin Trials. 1998 Feb;19(1):61-109
pubmed: 9492970
Cancer. 2016 May 1;122(9):1312-37
pubmed: 26959385
J Hepatol. 2019 Jan;70(1):151-171
pubmed: 30266282
Womens Health (Lond). 2009 Mar;5(2):191-203
pubmed: 19245356
J Nutr. 2018 May 1;148(5):771-780
pubmed: 29897561
Hepatology. 2019 Aug;70(2):577-586
pubmed: 30506561
Hepatology. 2014 Aug;60(2):588-97
pubmed: 24715615
BMJ. 2018 Jul 18;362:k2817
pubmed: 30021785
Eur J Epidemiol. 2005;20(7):575-9
pubmed: 16119429
Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):789-796
pubmed: 33514605
World J Gastroenterol. 2015 Jul 7;21(25):7613-20
pubmed: 26167064
World J Gastroenterol. 2018 Aug 28;24(32):3663-3670
pubmed: 30166861
Hepatol Commun. 2019 Jan 31;3(3):437-447
pubmed: 30859154
J Clin Invest. 2006 Jul;116(7):1793-801
pubmed: 16823477
Hepatol Res. 2013 Jan;43(1):51-64
pubmed: 23332087
Br J Nutr. 2016 Nov 28;116(10):1787-1798
pubmed: 27821188
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862